InBody Co.,Ltd (041830.KQ)

KRW 21950.0

(-1.13%)

Total Debt Summary of InBody Co.,Ltd

InBody Co.,Ltd's latest annual total debt in 2023 was 6.08 Billion KRW , down -4.95% from previous year.
InBody Co.,Ltd's latest quarterly total debt in 2024 Q2 was 7.53 Billion KRW , up 7.92% from previous quarter.
InBody Co.,Ltd reported annual total debt of 6.39 Billion KRW in 2022, up 65.41% from previous year.
InBody Co.,Ltd reported annual total debt of 3.86 Billion KRW in 2021, down -19.34% from previous year.
InBody Co.,Ltd reported quarterly total debt of 6.98 Billion KRW for 2024 Q1, up 14.84% from previous quarter.
InBody Co.,Ltd reported quarterly total debt of 6.08 Billion KRW for 2023 Q4, down -13.39% from previous quarter.

Annual Total Debt Chart of InBody Co.,Ltd (2023 - 2012)

Historical Annual Total Debt of InBody Co.,Ltd (2023 - 2012)

Year	Total Debt	Total Debt Growth
2023	6.08 Billion KRW	-4.95%
2022	6.39 Billion KRW	65.41%
2021	3.86 Billion KRW	-19.34%
2020	4.79 Billion KRW	87.2%
2019	2.56 Billion KRW	0.0%
2018	- KRW	0.0%
2017	- KRW	0.0%
2016	- KRW	0.0%
2015	- KRW	0.0%
2014	- KRW	0.0%
2013	- KRW	0.0%
2012	- KRW	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	7.53 Billion KRW	7.92%
2024 Q1	6.98 Billion KRW	14.84%
2023 Q4	6.08 Billion KRW	-13.39%
2023 FY	6.08 Billion KRW	-4.95%
2023 Q1	6.22 Billion KRW	-2.69%
2023 Q2	6.04 Billion KRW	-2.91%
2023 Q3	7.02 Billion KRW	16.15%
2022 FY	6.39 Billion KRW	65.41%
2022 Q4	6.39 Billion KRW	97.18%
2022 Q3	3.24 Billion KRW	-12.63%
2022 Q2	3.71 Billion KRW	-0.94%
2022 Q1	3.74 Billion KRW	-3.07%
2021 Q1	4.48 Billion KRW	59.69%
2021 Q3	4.27 Billion KRW	-5.89%
2021 Q4	3.86 Billion KRW	-9.48%
2021 Q2	4.53 Billion KRW	1.16%
2021 FY	3.86 Billion KRW	-19.34%
2020 Q2	3.84 Billion KRW	0.0%
2020 FY	4.79 Billion KRW	87.2%
2020 Q3	4.25 Billion KRW	10.71%
2020 Q1	- KRW	-100.0%
2020 Q4	2.8 Billion KRW	-34.0%
2019 Q4	2.56 Billion KRW	13.26%
2019 FY	2.56 Billion KRW	0.0%
2019 Q3	2.26 Billion KRW	0.0%
2019 Q2	- KRW	0.0%
2019 Q1	- KRW	0.0%
2018 Q1	- KRW	0.0%
2018 Q4	- KRW	-100.0%
2018 FY	- KRW	0.0%
2018 Q2	14.22 Billion KRW	0.0%
2018 Q3	6.54 Billion KRW	-53.95%
2017 FY	- KRW	0.0%
2017 Q4	- KRW	0.0%
2017 Q3	- KRW	0.0%
2017 Q1	- KRW	0.0%
2017 Q2	- KRW	0.0%
2016 Q4	- KRW	0.0%
2016 FY	- KRW	0.0%
2016 Q2	- KRW	0.0%
2016 Q1	- KRW	0.0%
2016 Q3	- KRW	0.0%
2015 Q3	- KRW	0.0%
2015 Q1	- KRW	0.0%
2015 FY	- KRW	0.0%
2015 Q4	- KRW	0.0%
2015 Q2	- KRW	0.0%
2014 Q3	- KRW	0.0%
2014 Q4	- KRW	0.0%
2014 Q2	- KRW	0.0%
2014 Q1	- KRW	0.0%
2014 FY	- KRW	0.0%
2013 Q2	- KRW	0.0%
2013 Q4	- KRW	0.0%
2013 FY	- KRW	0.0%
2013 Q1	- KRW	0.0%
2013 Q3	- KRW	0.0%
2012 Q3	- KRW	0.0%
2012 FY	- KRW	0.0%
2012 Q4	- KRW	0.0%

Peer Total Debt Comparison of InBody Co.,Ltd

Name	Total Debt	Total Debt Difference
Osang Healthcare Co.,Ltd	697.79 Million KRW	-771.358%
Curexo Inc.	2.05 Billion KRW	-195.251%
Seegene, Inc.	141.76 Billion KRW	95.711%
i-SENS, Inc.	143.79 Billion KRW	95.771%
Ray Co., Ltd.	86.67 Billion KRW	92.985%
Gencurix Inc.	17.95 Billion KRW	66.136%
Sugentech Inc.	15.3 Billion KRW	60.269%
L&C Bio Co., Ltd	82.13 Billion KRW	92.597%